Literature DB >> 21676120

Application of antimicrobial stewardship to optimise management of community acquired pneumonia.

J A Bosso1, R H Drew.   

Abstract

The aim of this study was to review the application of antimicrobial stewardship principles to the management of community-acquired pneumonia (CAP). Data from 14 published clinical studies, meta-analyses and practice guidelines regarding the application of antimicrobial stewardship strategies to the management of CAP were identified and analysed. In the context of CAP, application of stewardship strategies (alone or in combination) has been shown to increase physician awareness of guidelines, improve appropriate antimicrobial use and reduce unnecessary antimicrobial prescribing. In addition, application has had a profound favourable impact on patient outcomes, including decreased 30-day mortality and in-hospital mortality rates, reduced length of hospital stay, reduced treatment failure rates and reduced healthcare costs. Antimicrobial stewardship programmes have been demonstrated to successfully increase the level of appropriate antibiotic prescribing, reduce pathogen resistance and improve clinical outcomes in the management of CAP within hospitals. Studies have also shown that adherence to evidence-based guidelines, even at the level of the individual clinician, can have a profound and positive impact on patient outcomes and healthcare costs. Adherence to evidence-based guidelines can have a profound and positive impact on patient outcomes and healthcare costs.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21676120     DOI: 10.1111/j.1742-1241.2011.02704.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  15 in total

1.  Severe community-acquired pneumonia and positive urinary antigen test for S. pneumoniae: amoxicillin is associated with a favourable outcome.

Authors:  V Blanc; A Mothes; A Smetz; I Timontin; M D Guardia; A Billiemaz; J Dellamonica; M Vassallo; D Néri; S Chadapaud; A-L Toyer; P Del Guidice; A Fribourg; S Léotard; I Nicolle; P-M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-10-17       Impact factor: 3.267

2.  Development of antimicrobial competencies and training for staff hospital pharmacists.

Authors:  Marsha F Crader
Journal:  Hosp Pharm       Date:  2014-01

3.  A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections.

Authors:  R Murri; F Taccari; T Spanu; T D'Inzeo; I Mastrorosa; F Giovannenze; G Scoppettuolo; G Ventura; C Palazzolo; M Camici; S Lardo; B Fiori; M Sanguinetti; R Cauda; M Fantoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-19       Impact factor: 3.267

4.  Impact of antimicrobial stewardship programme on hospitalized patients at the intensive care unit: a prospective audit and feedback study.

Authors:  Maher R Khdour; Hussein O Hallak; Mamoon A Aldeyab; Mowaffaq A Nasif; Aliaa M Khalili; Ahamad A Dallashi; Mohammad B Khofash; Michael G Scott
Journal:  Br J Clin Pharmacol       Date:  2018-01-23       Impact factor: 4.335

5.  Community-acquired pneumonia: impact of empirical antibiotic therapy without respiratory fluoroquinolones nor third-generation cephalosporins.

Authors:  J Pradelli; K Risso; F G de Salvador; E Cua; R Ruimy; P-M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-02       Impact factor: 3.267

Review 6.  Pneumonia readmissions: risk factors and implications.

Authors:  Israel De Alba; Alpesh Amin
Journal:  Ochsner J       Date:  2014

7.  Antimicrobial stewardship - can we afford to do without it?

Authors:  Anna Aryee; Nicholas Price
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

Review 8.  A call to action for antimicrobial stewardship in the emergency department: approaches and strategies.

Authors:  Larissa May; Sara Cosgrove; Michelle L'Archeveque; David A Talan; Perry Payne; Jeanne Jordan; Richard E Rothman
Journal:  Ann Emerg Med       Date:  2012-11-02       Impact factor: 5.721

9.  E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae.

Authors:  David M Aronoff; Ingrid L Bergin; Casey Lewis; Deepti Goel; Edmund O'Brien; Marc Peters-Golden; Peter Mancuso
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-04-02       Impact factor: 3.072

Review 10.  Principles and Practice of Antibiotic Stewardship in the ICU.

Authors:  Chiagozie I Pickens; Richard G Wunderink
Journal:  Chest       Date:  2019-01-25       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.